Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (US20180222993) BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

Office : United States of America
Application Number: 15941524 Application Date: 30.03.2018
Publication Number: 20180222993 Publication Date: 09.08.2018
Publication Kind : A1
IPC:
C07K 16/28
A61P 25/00
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18
against material from animals or humans
28
against receptors, cell surface antigens or cell surface determinants
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
CPC:
A61P 25/00
C07K 16/2881
C07K 16/2887
C07K 2317/31
C07K 2317/515
C07K 2317/522
C07K 2317/55
C07K 2317/66
C07K 2317/92
C07K 2317/94
Applicants: Hoffmann-La Roche Inc.
Inventors: Harald DUERR
Sebastian FENN
Ulrich GOEPFERT
Sabine IMHOF-JUNG
Christian KLEIN
Laurent LARIVIERE
Michael MOLHOJ
Joerg Thomas REGULA
Petra RUEGER
Wolfgang SCHAEFER
Priority Data: 15188067.1 02.10.2015 EP
Title: (EN) BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE
Abstract:
(EN)

Herein are provided bispecific anti-human CD20/human transferrin receptor antibodies and methods of using the same.


Also published as:
UAa201804776AR106230AU2016333512CA2997801MYPI 2018701268IN201847011192
IL258317KR1020180054864CN108137697EP3356406MX2018003822ID2018/10050
PH1/2018/500710CR20180149WO/2017/055542